Loss of 5-Hydroxymethylcytosine as an Epigenetic Signature That Correlates With Poor Outcomes in Patients With Medulloblastoma.
Zhao F, Zhang ZW, Zhang J, Zhang S, Zhang H, Zhao C, Chen Y, Luo L, Tong WM, Li C, Niu Y, Liu P.
Zhao F, et al. Among authors: zhang s, zhang zw, zhang j, zhang h.
Front Oncol. 2021 Feb 24;11:603686. doi: 10.3389/fonc.2021.603686. eCollection 2021.
Front Oncol. 2021.
PMID: 33718152
Free PMC article.